Table 3.

Factors associated with prescribing sodium-glucose cotransporter-2 inhibitors among patients with stages 3–5 CKD and without diabetes

Characteristica	Adjusted Odds Ratio	95% Confidence Interval	P Value
Age, yr	0.95	0.94 to 0.96	<0.001
Men	3.48	2.36 to 5.13	<0.001
Race
White	ref
Black	1.86	1.04 to 3.31	0.04
Asian	0.89	0.22 to 3.66	0.87
Other/unknown	0.71	0.34 to 1.48	0.36
Heart failure	3.11	2.09 to 4.62	<0.001
RAAS inhibitor	2.16	1.53 to 3.06	<0.001
Diuretic	3.26	2.14 to 4.99	<0.001
CKD stages
3a	ref
3b	1.14	0.79 to 1.63	0.48
4	0.53	0.26 to 1.08	0.08
5	0.56	0.13 to 2.43	0.44
Urine dipstick test ordered	1.05	0.65 to 1.69	0.84
At least one nephrologist visit in the previous year	1.39	0.82 to 2.34	0.22
At least one cardiologist visit in the previous year	3.14	2.16 to 4.56	<0.001

CI, confidence interval; RAAS, renin-angiotensin-aldosterone system; ref, reference.

^aAll variables in the table were included in the multivariable logistic regression model.